CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib

詳細情報 詳細情報について

• CRID

  1362825895990004736

• DOI

  10.1007/s40259-019-00337-6

• ISSN

  1179190X

  11738804

• Web Site

  http://link.springer.com/content/pdf/10.1007/s40259-019-00337-6.pdf

  http://link.springer.com/article/10.1007/s40259-019-00337-6/fulltext.html

• データソース種別

  • Crossref